These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 7155358)

  • 1. Effects of the noradrenaline neurotoxin DSP4 on the postnatal development of central noradrenaline neurons in the rat.
    Jonsson G; Hallman H; Sundström E
    Neuroscience; 1982; 7(11):2895-907. PubMed ID: 7155358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DSP4 (N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine)--a useful denervation tool for central and peripheral noradrenaline neurons.
    Jonsson G; Hallman H; Ponzio F; Ross S
    Eur J Pharmacol; 1981 Jun; 72(2-3):173-88. PubMed ID: 6265244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological modifications of the neurotoxic action of the noradrenaline neurotoxin DSP4 on central noradrenaline neurons.
    Hallman H; Jonsson G
    Eur J Pharmacol; 1984 Aug; 103(3-4):269-78. PubMed ID: 6237924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recovery of central noradrenergic neurons one year after the administration of the neurotoxin DSP4.
    Wolfman C; Abó V; Calvo D; Medina J; Dajas F; Silveira R
    Neurochem Int; 1994 Oct; 25(4):395-400. PubMed ID: 7820072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Noradrenaline and dopamine interaction in rat brain during development.
    Ponzio F; Hallman H; Jonsson G
    Med Biol; 1981 Jun; 59(3):161-9. PubMed ID: 6796787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Response of central monoamine neurons following an early neurotoxic lesion.
    Jonsson G; Hallman H
    Bibl Anat; 1982; (23):76-92. PubMed ID: 6291505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A parametric study of the effects of the noradrenaline neurotoxin DSP4 on avoidance acquisition and noradrenaline neurones in the CNS of the rat.
    Archer T; Jonsson G; Ross SB
    Br J Pharmacol; 1984 May; 82(1):249-57. PubMed ID: 6733355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substance P modifies the 6-hydroxydopamine induced alteration of postnatal development of central noradrenaline neurons.
    Jonsson G; Hallman H
    Neuroscience; 1982; 7(11):2909-18. PubMed ID: 6185880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DSP4, a selective neurotoxin for the locus coeruleus noradrenergic system. A review of its mode of action.
    Ross SB; Stenfors C
    Neurotox Res; 2015 Jan; 27(1):15-30. PubMed ID: 24964753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of 6-hydroxydopamine on central noradrenaline neurons during ontogeny.
    Sachs C; Jonsson G
    Brain Res; 1975 Dec; 99(2):277-91. PubMed ID: 1182547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of the selective noradrenergic neurotoxin DSP4 on cerebellar Purkinje neuron electrophysiology.
    Bickford PC; Mosimann WF; Hoffer BJ; Freedman R
    Life Sci; 1984 Feb; 34(8):731-41. PubMed ID: 6422177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of oocyte release in rats by local administration of the noradrenergic neurotoxin DSP4.
    Goldman JM; Stoker TE; Cooper RL; McElroy WK; Parrish MB
    J Reprod Fertil; 1996 Mar; 106(2):275-83. PubMed ID: 8699411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DSP4-induced two-way active avoidance impairment in rats: involvement of central and not peripheral noradrenaline depletion.
    Archer T; Ogren SO; Johansson G; Ross SB
    Psychopharmacology (Berl); 1982; 76(4):303-9. PubMed ID: 6812102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DSP4 (N-2-chloroethyl-N-ethyl-2-bromobenzylamine), a new noradrenaline neurotoxin, and stimulus conditions affecting acquisition of two-way active avoidance.
    Archer T
    J Comp Physiol Psychol; 1982 Jun; 96(3):476-90. PubMed ID: 7096684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of selective noradrenergic denervation on noradrenaline content and [3H]dopamine release in rat nucleus accumbens slices.
    Russell VA; Lamm MC; Allin R; de Villiers AS; Searson A; Taljaard JJ
    Neurochem Res; 1989 Feb; 14(2):169-72. PubMed ID: 2725817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of the noradrenaline neurotoxin DSP 4 on monoamine neurons and their transmitter turnover in rat CNS.
    Hallman H; Sundström E; Jonsson G
    J Neural Transm; 1984; 60(2):89-102. PubMed ID: 6208323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical analysis of the neurotoxic effects of DSP-4 identifies two populations of noradrenergic axon terminals.
    Fritschy JM; Grzanna R
    Neuroscience; 1989; 30(1):181-97. PubMed ID: 2747911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T-maze learning, spontaneous activity and food intake recovery following systemic administration of the noradrenaline neurotoxin, DSP4.
    Archer T; Mohammed AK; Ross SB; Söderberg U
    Pharmacol Biochem Behav; 1983 Jul; 19(1):121-30. PubMed ID: 6684774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The neurotoxic compound N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine hydrochloride (DSP4) depletes endogenous norepinephrine and enhances release of [3H]norepinephrine from rat cortical slices.
    Landa ME; Rubio MC; Jaim-Etcheverry G
    J Pharmacol Exp Ther; 1984 Oct; 231(1):131-6. PubMed ID: 6491970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine (DSP4) on alpha2-adrenoceptors which regulate the synthesis and release of noradrenaline in the rat brain.
    Prieto M; Giralt MT
    Pharmacol Toxicol; 2001 Mar; 88(3):152-8. PubMed ID: 11245411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.